
Shares of Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) are building on recent gains, trading higher as investor focus intensifies on a key, upcoming catalyst. Here’s what investors need to know.
What To Know: The stock surged Tuesday following the release of the company’s second-quarter financial results, which painted a picture of forward-looking optimism despite mixed top-line numbers. Tonix posted a second-quarter net loss of $3.86 per share, beating the analyst consensus estimate of a $10.73 loss per share.